SNDX
Syndax Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$22.29-2.24%
Price as of Jul 20, 2026
SNDX valuation
Syndax Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 840.10x
- P/E 2028E
- 16.35x
- P/S forward
- 9.18x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 47.45x
- Price / sales
- 9.09x
- Price / cash flow
- -7.10x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 9.06x
- EV / EBITDA
- -12.11x
- EV / EBIT
- -8.81x
- Market cap
- $2.0B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.